期刊文献+

血液透析患者不宁腿综合征相关影响因素分析 被引量:10

Analysis of related factors for restless legs syndrome in hemodialysis patients
下载PDF
导出
摘要 目的调查血液透析患者不宁腿综合征发病率并筛查其相关危险因素。方法共220例维持性血液透析患者和40例慢性肾脏病患者,采用国际不宁腿综合征研究组评价量表(IRLS)评价不宁腿综合征严重程度,Beck抑郁量表(BDI)评价抑郁症状,Epworth嗜睡量表评价白天过度嗜睡,失眠严重程度指数(ISI)评价失眠程度。采用单因素和多因素前进法Logistic回归分析筛查血液透析患者发生不宁腿综合征的相关危险因素。结果血液透析组病程(Z=-9.837,P=0.000)、血清铁蛋白(t=2.847,P=0.005)、合并不宁腿综合征比例(χ~2=10.918,P=0.001)、应用镇静催眠药比例(χ~2=7.669,P=0.006)、IRLS评分(t=2.322,P=0.020)和ISI评分(Z=4.117,P=0.001)均高于对照组。单因素和多因素前进法Logistic回归分析显示,糖尿病(OR=3.387,95%CI:1.538~7.461;P=0.002)、BDI评分>9分(OR=2.643,95%CI:1.457~4.795;P=0.001)和ISI评分>7分(OR=3.542,95%CI:1.939~6.468;P=0.000)是血液透析患者发生不宁腿综合征的独立危险因素。结论血液透析患者不宁腿综合征和失眠发病率较高,不宁腿综合征与失眠密切相关,抑郁症状在其中发挥重要作用。 Objective To investigate the incidence of restless legs syndrome(RLS) in hemodialysis patients and to analyze the related risk factors. Methods There were 220 cases of hemodialysis as hemodialysis group and 40 cases of chronic nephrosis as control group. The severity of RLS was measured by International Restless Legs Syndrome Study Group Rating Scale(IRLS). Beck Depression Inventory(BDI) was used to evaluate the status of depression, Epworth Sleepiness Scale(ESS) was used to evaluate excessive daytime sleepiness(EDS), and Insomnia Severity Index(ISI) was used to evaluate the status of insomnia. Univariate and multivariate forward Logistic regression analysis was used to analyze the related risk factors for RLS in hemodialysis patients. Results In hemodialysis group duration(Z =. 9.837, P =0.000), serum ferritin(t = 2.847, P = 0.005), incidence rate of RLS(χ~2 = 10.918, P = 0.001), the proportion of using hypnotic drugs(χ~2 = 7.669, P = 0.006), IRLS(t = 2.322, P = 0.020) and ISI(Z = 4.117, P = 0.001) were significantly higher than control group. Univariate and multivariate forward Logistic regression analysis showed diabetes(OR = 3.387, 95%CI: 1.538-7.461; P = 0.002), BDI 9 score(OR = 2.643, 95%CI: 1.457-4.795; P = 0.001) and ISI 7 score(OR = 3.542, 95%CI: 1.939-6.468; P = 0.000) were independent risk factors for RLS in hemodialysis patients. Conclusions Hemodialysis patients have a high incidence of RLS and insomnia. RLS is closely related with insomnia. Depression plays an important role therein.
出处 《中国现代神经疾病杂志》 CAS 北大核心 2018年第1期55-59,共5页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 首都卫生发展科研专项项目(项目编号:首发2011-5002-04)~~
关键词 血液透析滤过 不宁腿综合征 危险因素 回归分析 Hemodiafihration Restless legs syndrome Risk factors Regresssion analysis
  • 相关文献

参考文献4

二级参考文献14

  • 1王梅.牛津临床透析手册.北京:人民卫生出版社,2006.124-125.
  • 2Waiters AS, Le Brocq C, Dhar A, et al. Validation of the Interna- tional Restless Legs Syndrome Study Group rating scale for rest- less legs Syndrome. Sleep Med,2003,4(2) :121 -132.
  • 3Waiters AS. Toward a better definition of the restless legs syn- drome:The international restless legs syndrome study group. Mor Disord, 1995,10 (4) :634 - 642.
  • 4Salman SM. Restless legs syndrome in patients on hemo-dialysis. Saudi J Kidney Dis Transpl, 2011, 22(2):368-372.
  • 5Lin CH, Wu YC, Li WY, et al. Restless legs syndromein end-stage renal disease: a multicentor study in Tai-wan. Eur J Neurol, 2013, 20(7):1025-1031.
  • 6Eryavuz N,Yuksel S, Acarturk G, et al. Comparison ofsleep quality between hemodialysis and peritoneal dial-ysis patients. Int Urol Nephro1, 2008,40(3):785~79i.
  • 7Allen RP, Picchietti D, Hening WA, et al. Restlesslogs syndrome: diagnostic criteria, special consider-ations and epidemiology. A report from the restlesslegs syndrome diagnosis and epidemiology workshop atthe National Institute of Health. Sleep Med, 2003,4(2):101-119.
  • 8Ganesh SK, Stack AG, Levin NW, et al. Association ofelevated serum P0 (4), Ca x P0(4) product, and parathy-roid hormone with cardiac mortality risk in chronic he-modialysis patients. J Am Soc Nephrol, 2001, 12(10):2131-2138.
  • 9Grote L, Leissner L, Hedner J, et al. A randomized,double- blind, placebo controlled, multi- conter studyof intravenous iron sucrose and placebo in the treat-ment of restless legs syndrome. Mov Disord, 2009, 24(10):1445-1452.
  • 10Hassan K, Simri W, Rubcnchik I, et al. Effect of eryth-ropoietin therapy on polyneuropathy in predialytic pa-tients. J Nephrol, 2003, 16 (1) : 121-125.

共引文献43

同被引文献104

引证文献10

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部